Ane Sørlie Kværner started as a postdoctoral fellow at the Section for Colorectal Cancer Screening in 2019. The postdoctoral position is affiliated with the research project " Intestinal bacteria and lifestyle in screening for colorectal cancer", a sub-project of "Screening for colorectal cancer". The overall purpose of the project is to find a biomarker for colorectal cancer through analysis of the intestinal flora of people with and without precancerous conditions. Sørlie Kværner is educated as a clinical nutritionist from the University of Oslo. She received her PhD in clinical nutrition from the Faculty of Medicine at the University of Oslo.
Ane Sørlie Kværner is a postdoctoral fellow at the Colorectal Cancer Screening Section.
The postdoctoral position is affiliated with the research project "Intestinal bacteria and lifestyle by screening for colorectal cancer", a subproject of "Screening for colorectal cancer".
The overall purpose of the project is to find a biomarker for colorectal cancer through analysis of the intestinal flora of people with and without precancerous conditions.
The hope is to find a microbial biomarker that can help improve screening services in the future. A secondary goal of this project is to investigate associations between diet, lifestyle, intestinal bacteria and precursors to colorectal cancer.
Increased knowledge about how our diet and lifestyle affect the cancer development process – in interaction with our intestinal bacteria – will contribute to more targeted prevention and treatment of colorectal cancer in the future.
Sørlie Kværner is educated as a clinical nutritionist from the University of Oslo.
She received her PhD in clinical nutrition from the Faculty of Medicine at the University of Oslo.
The work was about clinical and epidemiological research focusing on dietary and lifestyle habits before and after a colorectal cancer diagnosis.
Among other things, she studied how key risk factors for colorectal cancer such as obesity and an unfavourable metabolic profile affect disease risk throughout life.
Sørlie Kværner started as a postdoctoral fellow at the Cancer Registry of Norway in 2019.
Hang D, Kværner AS, Ma W, Hu Y, Tabung FK, Nan H, Hu Z, Shen H, Mucci LA, Chan AT, Giovannucci EL, Song M (2019)
Coffee consumption and plasma biomarkers of metabolic and inflammatory pathways in US health professionals
Am J Clin Nutr, 109 (3), 635-647
DOI 10.1093/ajcn/nqy295, PubMed 30834441
Kværner AS, Hang D, Giovannucci EL, Willett WC, Chan AT, Song M (2018)
Trajectories of body fatness from age 5 to 60 y and plasma biomarker concentrations of the insulin-insulin-like growth factor system
Am J Clin Nutr, 108 (2), 388-397
DOI 10.1093/ajcn/nqy103, PubMed 30101328
Hang D, He X, Kværner AS, Chan AT, Wu K, Ogino S, Hu Z, Shen H, Pollak MN, Giovannucci EL, Song M. Plasma Biomarkers of Insulin and the Insulin-like Growth Factor Axis, and Risk of Colorectal Adenoma and Serrated Polyp
JNCI Cancer Spectr. 1;3(3):pkz056.
DOI 10.1093/jncics/pkz056, PubMed: 32328558
Hang D, Nan H, Kværner AS, De Vivo I, Chan AT, Hu Z, Shen H, Giovannucci E, Song M (2018)
Longitudinal associations of lifetime adiposity with leukocyte telomere length and mitochondrial DNA copy number
Eur J Epidemiol, 33 (5), 485-495
DOI 10.1007/s10654-018-0382-z, PubMed 29619669
Henriksen HB, Ræder H, Bøhn SK, Paur I, Kværner AS, Billington SÅ, Eriksen MT, Wiedsvang G, Erlund I, Færden A, Veierød MB, Zucknick M, Smeland S, Blomhoff R (2017)
The Norwegian dietary guidelines and colorectal cancer survival (CRC-NORDIET) study: a food-based multicentre randomized controlled trial
BMC Cancer, 17 (1), 83
DOI 10.1186/s12885-017-3072-4, PubMed 28137255
See more publications on Pubmed
